Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

The pros, cons, and many unknowns of probiotics.

Suez J, Zmora N, Segal E, Elinav E.

Nat Med. 2019 May;25(5):716-729. doi: 10.1038/s41591-019-0439-x. Epub 2019 May 6. Review.

PMID:
31061539
2.

Probiotics in the next-generation sequencing era.

Suez J, Zmora N, Elinav E.

Gut Microbes. 2019 Apr 5:1-17. doi: 10.1080/19490976.2019.1586039. [Epub ahead of print]

PMID:
30951391
3.

You are what you eat: diet, health and the gut microbiota.

Zmora N, Suez J, Elinav E.

Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56. doi: 10.1038/s41575-018-0061-2. Review.

PMID:
30262901
4.

Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT.

Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, Horn M, Cohen Y, Moor AE, Zeevi D, Korem T, Kotler E, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Pevsner-Fischer M, Shapiro H, Sharon I, Halpern Z, Segal E, Elinav E.

Cell. 2018 Sep 6;174(6):1406-1423.e16. doi: 10.1016/j.cell.2018.08.047.

PMID:
30193113
5.

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features.

Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB, Federici S, Cohen Y, Linevsky R, Rothschild D, Moor AE, Ben-Moshe S, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Shapiro H, Pevsner-Fischer M, Sharon I, Halpern Z, Segal E, Elinav E.

Cell. 2018 Sep 6;174(6):1388-1405.e21. doi: 10.1016/j.cell.2018.08.041.

PMID:
30193112
6.

Sieving through gut models of colonization resistance.

Mullineaux-Sanders C, Suez J, Elinav E, Frankel G.

Nat Microbiol. 2018 Feb;3(2):132-140. doi: 10.1038/s41564-017-0095-1. Epub 2018 Jan 22. Review.

PMID:
29358683
7.

Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses.

Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E, Segal E.

Cell Metab. 2017 Jun 6;25(6):1243-1253.e5. doi: 10.1016/j.cmet.2017.05.002.

8.

The path towards microbiome-based metabolite treatment.

Suez J, Elinav E.

Nat Microbiol. 2017 May 25;2:17075. doi: 10.1038/nmicrobiol.2017.75.

PMID:
28540921
9.

Personalized microbiome-based approaches to metabolic syndrome management and prevention.

Shapiro H, Suez J, Elinav E.

J Diabetes. 2017 Mar;9(3):226-236. doi: 10.1111/1753-0407.12501. Review.

PMID:
27787945
10.

Personalized Nutrition by Prediction of Glycemic Responses.

Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalov√° L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E.

Cell. 2015 Nov 19;163(5):1079-1094. doi: 10.1016/j.cell.2015.11.001.

11.

Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples.

Korem T, Zeevi D, Suez J, Weinberger A, Avnit-Sagi T, Pompan-Lotan M, Matot E, Jona G, Harmelin A, Cohen N, Sirota-Madi A, Thaiss CA, Pevsner-Fischer M, Sorek R, Xavier R, Elinav E, Segal E.

Science. 2015 Sep 4;349(6252):1101-1106. doi: 10.1126/science.aac4812. Epub 2015 Jul 30.

12.

Non-caloric artificial sweeteners and the microbiome: findings and challenges.

Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E.

Gut Microbes. 2015;6(2):149-55. doi: 10.1080/19490976.2015.1017700. Epub 2015 Apr 1. Review.

13.

Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.

Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, Abramson L, Katz MN, Korem T, Zmora N, Kuperman Y, Biton I, Gilad S, Harmelin A, Shapiro H, Halpern Z, Segal E, Elinav E.

Cell. 2014 Oct 23;159(3):514-29. doi: 10.1016/j.cell.2014.09.048. Epub 2014 Oct 16.

14.

Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.

Levy M, Thaiss CA, Katz MN, Suez J, Elinav E.

Semin Immunopathol. 2015 Jan;37(1):39-46. doi: 10.1007/s00281-014-0451-7. Epub 2014 Oct 15. Review.

PMID:
25315349
15.

Artificial sweeteners induce glucose intolerance by altering the gut microbiota.

Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E.

Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.

PMID:
25231862
16.

A simple cage-autonomous method for the maintenance of the barrier status of germ-free mice during experimentation.

Hecht G, Bar-Nathan C, Milite G, Alon I, Moshe Y, Greenfeld L, Dotsenko N, Suez J, Levy M, Thaiss CA, Dafni H, Elinav E, Harmelin A.

Lab Anim. 2014 Oct;48(4):292-7. doi: 10.1177/0023677214544728. Epub 2014 Aug 5.

PMID:
25097255
17.

Integrative analysis of Salmonellosis in Israel reveals association of Salmonella enterica Serovar 9,12:l,v:- with extraintestinal infections, dissemination of endemic S. enterica Serovar Typhimurium DT104 biotypes, and severe underreporting of outbreaks.

Marzel A, Desai PT, Nissan I, Schorr YI, Suez J, Valinsky L, Reisfeld A, Agmon V, Guard J, McClelland M, Rahav G, Gal-Mor O.

J Clin Microbiol. 2014 Jun;52(6):2078-88. doi: 10.1128/JCM.00399-14. Epub 2014 Apr 9.

18.

The interplay between the innate immune system and the microbiota.

Thaiss CA, Levy M, Suez J, Elinav E.

Curr Opin Immunol. 2014 Feb;26:41-8. doi: 10.1016/j.coi.2013.10.016. Epub 2013 Nov 22. Review.

PMID:
24556399
19.

Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans.

Suez J, Porwollik S, Dagan A, Marzel A, Schorr YI, Desai PT, Agmon V, McClelland M, Rahav G, Gal-Mor O.

PLoS One. 2013;8(3):e58449. doi: 10.1371/journal.pone.0058449. Epub 2013 Mar 7.

20.

Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection.

Gal-Mor O, Suez J, Elhadad D, Porwollik S, Leshem E, Valinsky L, McClelland M, Schwartz E, Rahav G.

Clin Vaccine Immunol. 2012 Feb;19(2):146-56. doi: 10.1128/CVI.05468-11. Epub 2011 Dec 21.

Supplemental Content

Support Center